Leitlinie Gastroösophageale Refluxkrankheit 2022: Was ist neu?
Crossref DOI link: https://doi.org/10.1007/s15006-022-1890-z
Published Online: 2022-10-18
Published Print: 2022-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Labenz, Joachim
Text and Data Mining valid from 2022-10-01
Version of Record valid from 2022-10-01
Article History
First Online: 18 October 2022
Interessenkonflikt
: Honorare für Beratung und Vorträge von Bayer, Falk, Implantica, Luvos, Reckitt Benckiser, Schwabe; Forschungsunterstützung Reckitt Benckiser, Sofar